Table 1.

Significantly enriched GO terms and KEGG pathways.

Category	ID	Term	Bonferroni-adjusted pvalue
GO_BP	GO:0009954	proximal/distal pattern formation	1.1E-09
	GO:0048665	neuron fate specification	2.8E-08
	GO:0035115	embryonic forelimb morphogenesis	2.1E-07
	GO:0009952	anterior/posterior pattern specification	5.9E-07
	GO:0021522	spinal cord motor neuron differentiation	8.0E-05
	GO:0072189	ureter development	8.2E-05
	GO:0001764	neuron migration	9.8E-05
	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	1.3E-04
	GO:0045666	positive regulation of neuron differentiation	6.7E-04
	GO:0045665	negative regulation of neuron differentiation	1.1E-03
	GO:0007267	cell-cell signaling	1.1E-03
	GO:0035116	embryonic hindlimb morphogenesis	3.2E-03
	GO:0001759	organ induction	5.3E-03
	GO:0003148	outflow tract septum morphogenesis	9.6E-03
	GO:0002053	positive regulation of mesenchymal cell proliferation	1.5E-02
	GO:0007517	muscle organ development	2.2E-02
	GO:0009948	anterior/posterior axis specification	2.9E-02
	GO:0048557	embryonic digestive tract morphogenesis	3.2E-02
	GO:0048664	neuron fate determination	3.2E-02
	GO:0021527	spinal cord association neuron differentiation	3.2E-02
	GO:0032332	positive regulation of chondrocyte differentiation	3.2E-02
	GO:0048701	embryonic cranial skeleton morphogenesis	3.9E-02
GO_MF	GO:0043565	sequence-specific DNA binding	1.6E-10
	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	2.2E-10
	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	1.1E-06
	GO:0003682	chromatin binding	1.3E-06
	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	2.1E-02
GO_CC	GO:0005667	transcription factor complex	9.0E-06
	GO:0005634	nucleus	6.6E-03
KEGG	5200	Pathways in cancer	3.2E-04
	4080	Neuroactive ligand-receptor interaction	2.3E-03
	4950	Maturity onset diabetes of the young	3.2E-03